Goodbody Stockbrokers UC
04 August 2026
1Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
|
Name of exempt principal trader |
Goodbody Stockbrokers UC |
|
Company dealt in |
Irish Continental Group Plc |
|
Class of relevant security to which the dealings being disclosed relate (Note 1) |
Ordinary Shares |
|
Date of dealing |
31 July 2026 |
2. DEALINGS (Note 2)
(a) Purchases and sales
|
Total number of relevant securities acquired |
Highest price paid (Note 3) |
Lowest price paid (Note 3) |
|
50,000 |
7.94 |
7.9 |
|
Total number of securities disposed |
Highest price received (Note 3) |
Lowest price received (Note 3) |
|
50,000 |
7.9 |
7.9 |
(b) Derivatives transactions (other than options transactions)
|
Product name, e.g. CFD |
Nature of transaction (Note 4) |
Number of relevant securities (Note 5) |
Price per unit (Note 3) |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
|
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 5) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 3) |
(ii) Exercising
|
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 3) |
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
|
Date of disclosure |
04 August 2026 |
|
Contact name |
Jeremiah Bradley |
|
Telephone number |
+353 1 641 9291 |
|
Name of offeree/offeror with which connected |
Bluefin Bidco Limited |
|
Nature of connection (Note 6) |
Advisor to Offeror |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.